Sydney A. Gilman

Insider Reports History

Entity
Individual
Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sydney A. Gilman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. VP, Regulatory Affairs Stock Option (right to buy) 25K Jul 28, 2021 Direct
DiaMedica Therapeutics Inc. VP, Regulatory Affairs Voting Common Shares, no par value per share 0 $2.80 Jul 28, 2021 Direct

Insider Reports Filed by Sydney A. Gilman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jul 28, 2021 1 $0 4 Jul 29, 2021 VP, Regulatory Affairs